The secretome from human-derived mesenchymal stem cells augments the activity of antitumor plant extracts in vitro
JA Ramirez, MC Jiménez, V Ospina, BS Rivera… - Histochemistry and Cell …, 2024 - Springer
Cancer is understood as a multifactorial disease that involve multiple cell types and
phenotypes in the tumor microenvironment (TME). The components of the TME can interact …
phenotypes in the tumor microenvironment (TME). The components of the TME can interact …
Ribosome inactivation and the integrity of the intestinal epithelial barrier
SV Nikulin, NA Mnafki, SA Shilin, IN Gazizov… - Molecular Biology, 2018 - Springer
The mistletoe lectin viscumin (MLI) is a ribosome-inactivating protein from Viscum album
widely used in cancer therapy. Its antitumor properties are due to its immunomodulating …
widely used in cancer therapy. Its antitumor properties are due to its immunomodulating …
Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care …
FR Olayoku, NJD Verhoog, A Louw - Frontiers in Pharmacology, 2023 - frontiersin.org
Breast cancer is the most diagnosed type of cancer amongst women in economically
developing countries and globally. Most breast cancers express estrogen receptor alpha …
developing countries and globally. Most breast cancers express estrogen receptor alpha …
[PDF][PDF] Exploring the anticancer and anti-inflammatory activities of ferruginol in MCF-7 breast cancer cells
T Rengarajan, S Keerthiga, S Duraikannu… - Cancer …, 2019 - scholar.archive.org
Breast cancer is one of the most prevalent cancers in women, and it has the highest mortality
and morbidity worldwide. Breast cancer can be treated by hormone therapies, radiotherapy …
and morbidity worldwide. Breast cancer can be treated by hormone therapies, radiotherapy …
Evaluation of antitumoral and apoptotic potentials of masticadienonic acid and tirucallol from Pistacia vera L. stems
H Emlik, ID Karagoz, L Yabo-Dambagi… - Plant Biosystems-An …, 2023 - Taylor & Francis
Breast cancer is one of the most common forms of cancer in women, therefore it has become
necessary to find more effective and less toxic drugs to minimize the disadvantages of …
necessary to find more effective and less toxic drugs to minimize the disadvantages of …
The effect of coenzyme Q10 supplementation on vascular endothelial growth factor and serum levels of interleukin 6 and 8 in women with breast cancer: a double …
N Zahrooni, SA Hosseini, A Ahmadzadeh… - … and clinical risk …, 2019 - Taylor & Francis
Background To better evaluate the efficacy of CoQ10 on the inflammatory markers in breast
cancer patients, we conducted a clinical study of patients with breast cancer undergoing …
cancer patients, we conducted a clinical study of patients with breast cancer undergoing …
[HTML][HTML] Herbal Supplements
S Furhad, AA Bokhari - StatPearls [internet], 2024 - ncbi.nlm.nih.gov
Objectives: Identify the Food and Drug Administration regulations involving herbal
supplements. Assess the potential for inconsistency in herbal dosing. Evaluate the risks …
supplements. Assess the potential for inconsistency in herbal dosing. Evaluate the risks …
Significance of Oct‐4 transcription factor as a pivotal therapeutic target for CD44+/24− mammary tumor initiating cells: Aiming at the root of the recurrence
U Sen, S Shanavas, AH Nagendra… - Cell Biology …, 2023 - Wiley Online Library
Breast cancer (BC) remains one of the deadliest and frequently diagnosed metastatic
cancers worldwide. Cancer stem cells (CSCs) are the cell population within the tumor niche …
cancers worldwide. Cancer stem cells (CSCs) are the cell population within the tumor niche …
Complementary and Alternative Medicine Use among Cancer Patients in Iraq
HSI Al-shaikhli, R Al-Naggar… - Qubahan Academic …, 2024 - journal.qubahan.com
Complementary and alternative medicine (CAM) is becoming more popular among cancer
patients, but they may be reluctant to inform their medical team about it. As a result, this …
patients, but they may be reluctant to inform their medical team about it. As a result, this …
Fundamental Considerations of Targeted Drug Therapies for Breast Cancer
I Castillo-Tobías, L Berlanga, J Poblano… - Future …, 2023 - mdpi.com
Breast cancer is a complex disease for which pharmacological treatment does not
guarantee success or cure. In addition, current pharmacological therapies induce unwanted …
guarantee success or cure. In addition, current pharmacological therapies induce unwanted …